Science news articles about 'treatment resistant depression'

... this apparent depression circuit might provide significant benefit for patients with treatment-resistant depression." The researchers were able to track the clinical response of the patients over a ...

... . The data are reported in the on-line issue of Biological Psychiatry. Treatment-resistant depression is a recurrent psychiatric illness and a leading cause of premature morality due to suicide and ...

... . STAR*D provided evidence for step-by-step guidelines to address treatment-resistant depression and found that half of depressed patients became symptom-free or had major improvement after the first ...

... the country. STAR*D provided evidence for step-by-step guidelines to address treatment-resistant depression. Researchers found that only 33 percent of people go into remission in the first 12 weeks ...

... . Researchers have now explored ketamine's effects on suicidality in patients with treatment-resistant depression, and are publishing their results in the September 1st issue of Biological Psychiatry. ...

Use of drugs such as Abilify, Seroquel and Zyprexa for treatment-resistant depression is gaining ground. Some see an 'unmet need' for medication. Others worry about side effects. ...

... six-year, $35 million STAR*D study is the largest investigation on the treatment of major ... step guidelines to address treatment-resistant depression. Many treatment-resistant depression patients would ...

... treat all depression," says Dr. Lee. "It should be reserved for those patients who have treatment-resistant depression and approved by a multi-disciplinary team." Ongoing advances in DBS technologies ...